CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. – Neurocrine Biosciences, Inc. Transaction History
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. portfolio value:
$20.95M
portfolio value
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.10% | -17.38K shares | 27K | $106.21 | 197.30K |
| Q2 2022 | share | Increase | +2.43% | 5.09K shares | 1.27M | $97.48 | 214.69K |
| Q1 2022 | share | Increase | +302.40% | 157.51K shares | 15.21M | $93.75 | 209.59K |
| Q4 2021 | share | Increase | 0.00% | 52.08K shares | 4.43M | $84.63 | 52.08K |
| Q2 2021 | share | Decrease | -100.00% | -4.58K shares | -446K | $97.32 | 0 |
| Q1 2021 | share | Increase | 0.00% | 4.58K shares | 446K | $97.25 | 4.58K |
| Q4 2020 | share | Decrease | -100.00% | -10.49K shares | -1.01M | $95.85 | 0 |
| Q3 2020 | share | Increase | 0.00% | 10.49K shares | 1.01M | $96.16 | 10.49K |
| Q4 2018 | share | Decrease | -100.00% | -2.97K shares | -366K | $71.41 | 0 |
| Q3 2018 | share | Increase | 0.00% | 2.97K shares | 366K | $122.95 | 2.97K |